219 related articles for article (PubMed ID: 32413995)
1. Expression of the Long Noncoding RNA GAS5 Correlates with Liver Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.
Han MH; Lee JH; Kim G; Lee E; Lee YR; Jang SY; Lee HW; Chun JM; Han YS; Yoon JS; Kang MK; Lee WK; Kweon YO; Tak WY; Park SY; Park JG; Hur K
Genes (Basel); 2020 May; 11(5):. PubMed ID: 32413995
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA GAS5 contributes to the progression of nonalcoholic fatty liver disease by targeting the microRNA-29a-3p/NOTCH2 axis.
Cui J; Wang Y; Xue H
Bioengineered; 2022 Apr; 13(4):8370-8381. PubMed ID: 35322757
[TBL] [Abstract][Full Text] [Related]
3. GAS5 protects against nonalcoholic fatty liver disease via miR-28a-5p/MARCH7/NLRP3 axis-mediated pyroptosis.
Chen T; Meng Y; Zhou Z; Li H; Wan L; Kang A; Guo W; Ren K; Song X; Chen Y; Zhao W
Cell Death Differ; 2023 Jul; 30(7):1829-1848. PubMed ID: 37337032
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of lncRNA HULC improves hepatic fibrosis and hepatocyte apoptosis by inhibiting the MAPK signaling pathway in rats with nonalcoholic fatty liver disease.
Shen X; Guo H; Xu J; Wang J
J Cell Physiol; 2019 Aug; 234(10):18169-18179. PubMed ID: 30908654
[TBL] [Abstract][Full Text] [Related]
5. Long noncoding RNAs in nonalcoholic fatty liver disease and liver fibrosis: state-of-the-art and perspectives in diagnosis and treatment.
De Vincentis A; Rahmani Z; Muley M; Vespasiani-Gentilucci U; Ruggiero S; Zamani P; Jamialahmadi T; Sahebkar A
Drug Discov Today; 2020 Jul; 25(7):1277-1286. PubMed ID: 32439605
[TBL] [Abstract][Full Text] [Related]
6. Epigenetically-regulated serum GAS5 as a potential biomarker for patients with chronic hepatitis B virus infection.
Guo Y; Li C; Zhang R; Zhan Y; Yu J; Tu J; Zheng J
Cancer Biomark; 2021; 32(2):137-146. PubMed ID: 34092613
[TBL] [Abstract][Full Text] [Related]
7. lncRNA GAS5 restrains CCl
Dong Z; Li S; Wang X; Si L; Ma R; Bao L; Bo A
Am J Physiol Gastrointest Liver Physiol; 2019 Apr; 316(4):G539-G550. PubMed ID: 30735452
[TBL] [Abstract][Full Text] [Related]
8. High-throughput sequencing reveals altered expression of hepatic microRNAs in nonalcoholic fatty liver disease-related fibrosis.
Leti F; Malenica I; Doshi M; Courtright A; Van Keuren-Jensen K; Legendre C; Still CD; Gerhard GS; DiStefano JK
Transl Res; 2015 Sep; 166(3):304-14. PubMed ID: 26001595
[TBL] [Abstract][Full Text] [Related]
9. Long noncoding RNA-GAS5 retards renal fibrosis through repressing miR-21 activity.
Yu Y; Jiang H; Niu Y; Huang J; Zhang X; Liu X; Zhang Y; Liu S; Fu H; Yu C
Exp Mol Pathol; 2020 Oct; 116():104518. PubMed ID: 32791063
[TBL] [Abstract][Full Text] [Related]
10. Expression of insulin-like growth factor I and its receptor in the liver of children with biopsy-proven NAFLD.
Alisi A; Pampanini V; De Stefanis C; Panera N; Deodati A; Nobili V; Cianfarani S
PLoS One; 2018; 13(7):e0201566. PubMed ID: 30063751
[TBL] [Abstract][Full Text] [Related]
11. Long Non-coding RNA Growth Arrest-specific Transcript 5 (GAS5) Inhibits Liver Fibrogenesis through a Mechanism of Competing Endogenous RNA.
Yu F; Zheng J; Mao Y; Dong P; Lu Z; Li G; Guo C; Liu Z; Fan X
J Biol Chem; 2015 Nov; 290(47):28286-28298. PubMed ID: 26446789
[TBL] [Abstract][Full Text] [Related]
12. Altered expression of MALAT1 lncRNA in nonalcoholic steatohepatitis fibrosis regulates CXCL5 in hepatic stellate cells.
Leti F; Legendre C; Still CD; Chu X; Petrick A; Gerhard GS; DiStefano JK
Transl Res; 2017 Dec; 190():25-39.e21. PubMed ID: 28993096
[TBL] [Abstract][Full Text] [Related]
13. Steatosis induced CCL5 contributes to early-stage liver fibrosis in nonalcoholic fatty liver disease progress.
Li BH; He FP; Yang X; Chen YW; Fan JG
Transl Res; 2017 Feb; 180():103-117.e4. PubMed ID: 27639593
[TBL] [Abstract][Full Text] [Related]
14. Fibronectin Type III Domain-Containing Protein 5 rs3480 A>G Polymorphism, Irisin, and Liver Fibrosis in Patients With Nonalcoholic Fatty Liver Disease.
Petta S; Valenti L; Svegliati-Baroni G; Ruscica M; Pipitone RM; Dongiovanni P; Rychlicki C; Ferri N; Cammà C; Fracanzani AL; Pierantonelli I; Di Marco V; Meroni M; Giordano D; Grimaudo S; Maggioni M; Cabibi D; Fargion S; Craxì A
J Clin Endocrinol Metab; 2017 Aug; 102(8):2660-2669. PubMed ID: 28472477
[TBL] [Abstract][Full Text] [Related]
15. The Roles and Mechanisms of lncRNAs in Liver Fibrosis.
He Z; Yang D; Fan X; Zhang M; Li Y; Gu X; Yang M
Int J Mol Sci; 2020 Feb; 21(4):. PubMed ID: 32098245
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of murine long noncoding single-cell transcriptome in nonalcoholic steatohepatitis and liver fibrosis.
Karri K; Waxman DJ
RNA; 2023 Jul; 29(7):977-1006. PubMed ID: 37015806
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA GAS5 inhibits cell proliferation and fibrosis in diabetic nephropathy by sponging miR-221 and modulating SIRT1 expression.
Ge X; Xu B; Xu W; Xia L; Xu Z; Shen L; Peng W; Huang S
Aging (Albany NY); 2019 Oct; 11(20):8745-8759. PubMed ID: 31631065
[TBL] [Abstract][Full Text] [Related]
18. The role of bile acids in nonalcoholic fatty liver disease and nonalcoholic steatohepatitis.
Chow MD; Lee YH; Guo GL
Mol Aspects Med; 2017 Aug; 56():34-44. PubMed ID: 28442273
[TBL] [Abstract][Full Text] [Related]
19. Ultrasonographic Nonalcoholic Fatty Pancreas Is Associated with Advanced Fibrosis in NAFLD: A Retrospective Analysis.
Rosenblatt R; Mehta A; Snell D; Hissong E; Kierans AS; Kumar S
Dig Dis Sci; 2019 Jan; 64(1):262-268. PubMed ID: 30269271
[TBL] [Abstract][Full Text] [Related]
20. Low expression of long non-coding RNA GAS5 is associated with poor prognosis of patients with thyroid cancer.
Guo LJ; Zhang S; Gao B; Jiang Y; Zhang XH; Tian WG; Hao S; Zhao JJ; Zhang G; Hu CY; Yan J; Luo DL
Exp Mol Pathol; 2017 Jun; 102(3):500-504. PubMed ID: 28506768
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
